Literature DB >> 34199277

Adropin Slightly Modulates Lipolysis, Lipogenesis and Expression of Adipokines but Not Glucose Uptake in Rodent Adipocytes.

Mariami Jasaszwili1, Ewa Pruszyńska-Oszmałek1, Tatiana Wojciechowicz1, Mathias Z Strowski2,3, Krzysztof W Nowak1, Marek Skrzypski1.   

Abstract

Adropin is a peptide hormone which modulates energy homeostasis and metabolism. In animals with diet-induced obesity, adropin attenuates adiposity and improves lipid and glucose homeostasis. Adropin promotes the proliferation of rodent white preadipocytes and suppresses their differentiation into adipocytes. By contrast, the effects of adropin on mature white adipocytes are unknown. Therefore, we aimed to evaluate the effects of adropin on lipolysis, lipogenesis and glucose uptake in white rodent adipocytes. We assessed the effects of adropin on the mRNA expression of adiponectin, resistin and visfatin. White preadipocytes were isolated from male Wistar rats. Differentiated 3T3-L1 cells were used as a surrogate model of white adipocytes. Lipolysis was measured by the evaluation of glycerol and free fatty acid secretion using colorimetric kits. The effects of adropin on lipogenesis and glucose uptake were measured using radioactive-labelled glucose. The expression of adipokine mRNA was studied using real-time PCR. Our results show that adropin slightly promotes lipolysis in rat adipocytes and 3T3-L1 cells. Adropin suppresses lipogenesis in rat adipocytes without influencing glucose uptake. In addition, adropin stimulates adiponectin mRNA expression and suppresses the expression of resistin and visfatin. These results indicate that adropin may be involved in controlling lipid metabolism and adipokine expression in white rodent adipocytes.

Entities:  

Keywords:  3T3-L1; adipocytes; adipokines; adropin; glucose uptake; lipogenesis; lipolysis

Mesh:

Substances:

Year:  2021        PMID: 34199277      PMCID: PMC8231953          DOI: 10.3390/genes12060914

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  45 in total

1.  G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells.

Authors:  Angad Rao; Deron R Herr
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-05-02       Impact factor: 4.739

2.  The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity.

Authors:  Su Gao; Sarbani Ghoshal; Liyan Zhang; Joseph R Stevens; Kyle S McCommis; Brian N Finck; Gary D Lopaschuk; Andrew A Butler
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

Review 3.  Adipokines in health and disease.

Authors:  Mathias Fasshauer; Matthias Blüher
Journal:  Trends Pharmacol Sci       Date:  2015-05-25       Impact factor: 14.819

4.  Circulating adropin and vascular endothelial growth factor receptor-2 levels in age-related macular degeneration and T2DM patients-A cross-sectional study.

Authors:  Areekulangara Neethu; Kuppuswami Jayashree; Gandhipuram Periyasamy Senthilkumar; K Ramesh Babu; Mehalingam Vadivelan
Journal:  J Family Med Prim Care       Date:  2020-09-30

5.  A novel hormone-sensitive lipase isoform expressed in pancreatic beta-cells.

Authors:  Håkan Lindvall; Pernilla Nevsten; Kristoffer Ström; Reine Wallenberg; Frank Sundler; Dominique Langin; Maria Sörhede Winzell; Cecilia Holm
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

6.  Serum adropin levels are decreased in patients with acute myocardial infarction.

Authors:  Hou-you Yu; Peng Zhao; Ming-chun Wu; Jian Liu; Wen Yin
Journal:  Regul Pept       Date:  2014-04-13

7.  Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.

Authors:  Lisa Patel; Amy C Buckels; Ian J Kinghorn; Paul R Murdock; Joanna D Holbrook; Christopher Plumpton; Colin H Macphee; Stephen A Smith
Journal:  Biochem Biophys Res Commun       Date:  2003-01-10       Impact factor: 3.575

8.  Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.

Authors:  Dharendra Thapa; Bingxian Xie; Janet R Manning; Manling Zhang; Michael W Stoner; Brydie R Huckestein; Lia R Edmunds; Xueyang Zhang; Nikolaos L Dedousis; Robert M O'Doherty; Michael J Jurczak; Iain Scott
Journal:  Physiol Rep       Date:  2019-04

9.  Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes.

Authors:  Yu Jung Heo; Sung-E Choi; Ja Young Jeon; Seung Jin Han; Dae Jung Kim; Yup Kang; Kwan Woo Lee; Hae Jin Kim
Journal:  J Diabetes Res       Date:  2019-07-17       Impact factor: 4.011

View more
  4 in total

1.  Serum Adropin Levels in Patients with Rheumatoid Arthritis.

Authors:  Petra Simac; Dijana Perkovic; Ivona Bozic; Nada Bilopavlovic; Dinko Martinovic; Josko Bozic
Journal:  Life (Basel)       Date:  2022-01-24

2.  An association between adropin hormone and total testosterone in obese men: a case-control study.

Authors:  Asmaa A Muhammed; Rania M H M Eid; Wafaa Salah Mohammed; Mahmoud R Abdel-Fadeil
Journal:  BMC Endocr Disord       Date:  2022-07-27       Impact factor: 3.263

3.  Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum.

Authors:  Marek Skrzypski; Paweł A Kołodziejski; Ewa Pruszyńska-Oszmałek; Tatiana Wojciechowicz; Paulina Janicka; Małgorzata Krążek; Emilian Małek; Mathias Z Strowski; Krzysztof W Nowak
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

Review 4.  Sex Differences in Adiposity and Cardiovascular Diseases.

Authors:  Haoyun Li; Daniels Konja; Luyao Wang; Yu Wang
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.